Personal stem cells tested as potential Parkinson's treatment
NCT ID NCT06056427
Summary
This expanded access program allowed up to 11 patients with early to moderate Parkinson's disease to receive their own banked stem cells intravenously. The trial aimed to evaluate whether these stem cells could help control Parkinson's symptoms and slow disease progression. Participants had previously screened for but weren't selected for a related Phase 2 study, giving them access to this experimental treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.